lncRNA MIR210HG在子痫前期胎盘组织中的表达及功能分析
该研究纳入39例子痫前期产妇和39例正常妊娠产妇,通过转录组测序发现胎盘组织中26个差异表达的lncRNA。MIR210HG在子痫前期胎盘组织中表达上调,与收缩压、舒张压呈正相关,与新生儿出生体重呈负相关;敲低MIR210HG可促进HTR8/SVneo细胞增殖和迁移。
要点
- 子痫前期胎盘组织中MIR210HG表达显著上调。
- MIR210HG表达与血压正相关、与新生儿出生体重负相关。
- 敲低MIR210HG促进滋养层细胞增殖和迁移。
核心结论
- lncRNA MIR210HG在子痫前期产妇胎盘组织中表达上调,可能是滋养层细胞生物学行为的调节因子。
研究设计与样本
- 研究纳入2018年7月至2019年7月青岛大学附属医院收治的子痫前期产妇39例和正常妊娠产妇39例。
- 采用转录组测序分析胎盘组织差异表达lncRNA,实时荧光定量PCR检测MIR210HG表达并分析其与收缩压、舒张压和新生儿出生体重的相关性。
- 构建siRNA转染HTR8/SVneo细胞敲低MIR210HG,分为敲低组和阴性对照组,用CCK-8法和transwell实验检测增殖和迁移能力。
- 采用ENCORI数据库预测与MIR210HG相互作用的RNA,并行GO、KEGG和BioCarta通路富集分析。
主要发现
- RNA-seq共检测出26个显著差异表达的lncRNA,其中21个上调、5个下调。
- MIR210HG在子痫前期组胎盘组织中的相对表达水平显著高于对照组(分别为9.30±1.90和1.10±0.20;t=4.425,P<0.01)。
- MIR210HG表达水平与收缩压呈线性正相关(r2=0.234,P<0.05),与舒张压呈线性正相关(r2=0.190,P<0.05),与新生儿出生体重呈线性负相关(r2=0.157,P<0.05)。
- 与阴性对照组相比,敲低组HTR8/SVneo细胞的增殖和迁移能力均显著增强(P均<0.05)。
- ENCORI数据库预测出38个可能与MIR210HG相互作用的RNA;GO分析显示可能参与27条通路,KEGG分析显示可能参与8条通路,BioCarta分析显示可能参与8条通路。
关键数值与推荐
- 子痫前期组MIR210HG相对表达量为9.30±1.90,对照组为1.10±0.20(t=4.425,P<0.01)。
- MIR210HG与收缩压相关性r2=0.234(P<0.05),与舒张压r2=0.190(P<0.05),与新生儿出生体重r2=0.157(P<0.05)。
- 敲低MIR210HG后HTR8/SVneo细胞增殖和迁移能力增强(P均<0.05)。
临床怎么用
- MIR210HG在子痫前期胎盘组织中表达上调,可作为探索子痫前期发病机制的候选分子。
- MIR210HG表达与血压和新生儿出生体重相关,提示其可能参与子痫前期的临床表型。
- 敲低MIR210HG促进滋养层细胞增殖和迁移,提示其可能调控滋养细胞生物学行为。
局限性
- 研究为单中心样本,样本量有限(子痫前期组39例、对照组39例)。
- 机制分析主要基于数据库预测和体外细胞实验,未在体内或更大样本中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the differential expression of long non-coding RNA (lncRNA) in placental tissues of women with preeclampsia (PE) and the effect of MIR210HG on the biological function of HTR8/SVneo cells. Methods: A total of 39 cases of PE women (PE group) and 39 cases of normal pregnant women (CTL group) admitted to the Affiliated Hospital of Qingdao University from July 2018 to July 2019 were collected. (1) Transcriptome sequencing (RNA-seq) was used to analyze the differentially expressed lncRNAs in the placental tissues of the two groups. (2) The expression level of MIR210HG, one of the differentially expressed lncRNAs, in the placental tissues of the two groups was detected by real-time quantitative PCR. And the correlations between the expression level of MIR210HG and systolic blood pressure, diastolic blood pressure and neonatal birth weight were analyzed. (3) The constructed small interfering RNA and negative control (NC) RNA were transfected into the HTR8/SVneo cells. The cells were divided into MIR210HG knockdown (KD) group and NC group. The effects of living cell counting (CCK-8) and transwell assay on the proliferation and migration of HTR8/SVneo cells were detected. (4) RNA interacting with MIR210HG was predicted using the Encyclopedia of RNA Interactomes (ENCORI) database. Gene Ontology (GO) functional annotation, Kyoto Encyclopedia of Gene and Genomes (KEGG) and BioCarta pathway enrichment analysis were performed. Results: (1) A total of 26 significantly differentially expressed lncRNAs were found by RNA-seq, among which 21 lncRNAs were up-regulated and 5 lncRNAs were down-regulated. (2) The relative expression level of MIR210HG in the PE group was significantly higher than that in the CTL group (9.30±1.90 and 1.10±0.20, respectively; t=4.425, P<0.01). The relative expression level of MIR210HG had positive linear correlation with systolic blood pressure (r2=0.234, P<0.05) and diastolic blood pressure (r2=0.190, P<0.05), but had a negative linear correlation with newborn birth weight (r2=0.157, P<0.05). (3) Compared with the NC group, the proliferation and migration ability of HTR8/SVneo cells in the KD group were increased (all P<0.05). (4) A total of 38 RNAs that might interact with MIR210HG were predicted by ENCORI database. GO functional annotation analysis showed that MIR210HG might be involved in the functions of 27 pathways, including the regulation of production of molecular mediator of immune response, etc; KEGG pathway analysis showed that MIR210HG might be involved in the function of 8 pathways including allograft rejection, etc; Biocarta pathway analysis showed that MIR210HG may be involved in the functions of 8 pathways, including the eukaryotic initiation factor (eIF) pathway, etc. Conclusion: The expression of MIR210HG is up-regulated in the placental tissue of PE women, and MIR210HG might be a regulator of the biological behavior of trophoblast cells. 目的: 研究子痫前期(PE)产妇胎盘组织中长链非编码RNA(lncRNA)的差异表达及其中之一MIR210HG对绒毛膜滋养层细胞系HTR8/SVneo细胞生物学特性的影响,并对MIR210HG进行功能分析。 方法: 选取2018年7月至2019年7月青岛大学附属医院收治的PE产妇39例(PE组)和同期正常妊娠产妇39例(对照组)。(1)采用转录组测序(RNA-seq)技术分析两组产妇胎盘组织中差异表达的lncRNA;实时荧光定量PCR技术方法检测两组产妇胎盘组织中差异表达的lncRNA之一MIR210HG的表达水平,并分析MIR210HG表达水平与收缩压、舒张压和新生儿出生体重的相关性。(2)构建小分子干扰RNA(siRNA),转染HTR8/SVneo细胞以敲低MIR210HG的表达,实验分为两组,即MIR210HG敲低(KD)组(HTR8/SVneo细胞转染siRNA敲低了MIR210HG的表达)和阴性对照(NC)组(HTR8/SVneo细胞转染NC siRNA),采用活细胞计数(CCK-8)法、穿膜小室(transwell小室)体外实验检测两组HTR8/SVneo细胞增殖和迁移能力的变化。(3)采用RNA相互作用百科全书(ENCORI)数据库预测与MIR210HG相互作用的RNA,并采用基因本体(GO)功能注释、京都基因和基因组百科全书(KEGG)和BioCarta通路富集方法对MIR210HG的功能进行分析。 结果: (1)RNA-seq技术共检测出显著差异表达的lncRNA 26个,其中表达上调21个、下调5个。MIR210HG在PE组产妇胎盘组织中的表达水平显著高于对照组(分别为9.30±1.90、1.10±0.20;t=4.425,P<0.01);MIR210HG的表达水平与收缩压(r2=0.234,P<0.05)和舒张压(r2=0.190,P<0.05)均呈线性正相关关系,与新生儿出生体重呈线性负相关关系(r2=0.157,P<0.05)。(2)与NC组相比,KD组HTR8/SVneo细胞的增殖和迁移能力均显著增强(P均<0.05)。(3)ENCORI数据库分析共预测出可能与MIR210HG相互作用的RNA 38个。GO功能注释分析显示,MIR210HG可能参与免疫应答分子中介物产生的调控等27条通路的功能;KEGG通路富集显示,MIR210HG可能参与同种异体移植物排斥等8条通路的功能;BioCarta通路富集显示,MIR210HG可能参与翻译起始因子通路等8条通路的功能。 结论: lncRNA MIR210HG在PE产妇的胎盘组织中表达上调,降低MIR210HG的表达水平可促进HTR8/SVneo细胞的增殖和迁移,MIR210HG可能是滋养层细胞生物学行为的调节因子。.
引用
- Li XL, Zhang L, Hou B, et al. [Expression of lncRNA MIR210HG in preeclampsia placental tissue and its functional analysis]. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34154318. doi:10.3760/cma.j.cn112141-20210118-00029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。